文献速递关节外科

先进金属伪影减少MRI对肩关节假体周围感染的诊断性能

Diagnostic Performance of Advanced Metal Artifact Reduction MRI for Periprosthetic Shoulder Infection.
PubMed 文献 · J Bone Joint Surg Am · 2022-06-21

研究纳入2015年1月至2019年12月连续89例疑似肩关节假体周围感染(PSI)患者,采用先进金属伪影减少(MARS)MRI并由两位放射科医生盲法独立评估。以国际共识会议(ICM)2018标准为参考,22例(25%)判定感染、67例(75%)未感染;淋巴结肿大、复杂关节积液和水肿性滑膜炎诊断PSI的敏感度均>85%、特异度均>90%、比值比均>3.6、AUC均>0.90,三者同时存在时PSI概率>99%。

要点

  • 先进MARS-MRI观察者间信度和观察者内重复性良好至优秀(κ=0.61至>0.80)。
  • 淋巴结肿大、复杂关节积液和水肿性滑膜炎诊断PSI的敏感度均>85%、特异度均>90%。
  • 三项征象同时存在时PSI概率>99%(logistic回归分析)。

核心结论

  • 以ICM 2018标准为参考,先进MARS-MRI对诊断PSI具有临床实用性;可靠性和诊断准确性高,但结论基于本研究的特定MARS-MRI方案及有经验的肌骨放射科医生判读。
  • 需要更大样本量的研究来证实这些结果。

研究设计与样本

  • 2015年1月至2019年12月在本学术医院连续纳入疑似PSI患者89例,所有参与者均有至少1年临床随访。
  • 全部参与者接受标准化临床、影像学和实验室评估及先进MARS-MRI检查。
  • 两位接受过专科培训的肌骨放射科医生以盲法、独立方式回顾性评估先进MARS-MRI上与PSI相关的征象,间隔2个月后重复评估。
  • 采用κ系数评估观察者间信度和观察者内重复性;采用敏感度、特异度和受试者工作特征曲线下面积(AUC)量化诊断性能。
  • 应用ICM 2018标准,89例中22例(25%)判定为感染,67例(75%)判定为未感染(1年随访期间不太可能为PSA且无需手术)。

主要发现

  • 先进MARS-MRI征象(淋巴结肿大、关节积液、滑膜炎、关节外积液、窦道、肩袖肌肉水肿和假体周围骨吸收)的观察者间信度和观察者内重复性为良好(κ=0.61至0.80)至优秀(κ>0.80)。
  • 淋巴结肿大、复杂关节积液和水肿性滑膜炎诊断PSI的敏感度均>85%、特异度均>90%、比值比均>3.6、AUC均>0.90。
  • 三项征象同时存在时,经logistic回归分析得出PSI概率>99%。

关键数值与推荐

  • 以ICM 2018标准为参考,89例中22例(25%)判定为感染,67例(75%)判定为未感染(1年随访期间不太可能为PSA且无需手术)。
  • 淋巴结肿大、复杂关节积液和水肿性滑膜炎诊断PSI的敏感度均>85%、特异度均>90%、比值比均>3.6、AUC均>0.90。
  • 三项征象同时存在时PSI概率>99%(logistic回归分析)。
  • 各征象观察者间信度和观察者内重复性κ=0.61至0.80为良好,κ>0.80为优秀。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 结论基于本研究的特定先进MARS-MRI方案及有经验的肌骨放射科医生判读。
  • 需要更大样本量的研究来证实这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The diagnosis of periprosthetic shoulder infection (PSI) in patients with a painful arthroplasty is challenging. Magnetic resonance imaging (MRI) may be helpful, but shoulder implant-induced metal artifacts degrade conventional MRI. Advanced metal artifact reduction (MARS) improves the visibility of periprosthetic bone and soft tissues. The purpose of our study was to determine the reliability, repeatability, and diagnostic performance of advanced MARS-MRI findings for diagnosing PSI. METHODS: Between January 2015 and December 2019, we enrolled consecutive patients suspected of having PSI at our academic hospital. All 89 participants had at least 1-year clinical follow-up and underwent standardized clinical, radiographic, and laboratory evaluations and advanced MARS-MRI. Two fellowship-trained musculoskeletal radiologists retrospectively evaluated the advanced MARS-MRI studies for findings associated with PSI in a blinded and independent fashion. Both readers repeated their evaluations after a 2-month interval. Interreader reliability and intrareader repeatability were assessed with κ coefficients. The diagnostic performance of advanced MARS-MRI for PSI was quantified using sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC). When applying the International Consensus Meeting (ICM) 2018 criteria, of the 89 participants, 22 (25%) were deemed as being infected and 67 (75%) were classified as being not infected (unlikely to have PSA and not requiring a surgical procedure during 1-year follow-up). RESULTS: The interreader reliability and intrareader repeatability of advanced MARS-MRI findings, including lymphadenopathy, joint effusion, synovitis, extra-articular fluid collection, a sinus tract, rotator cuff muscle edema, and periprosthetic bone resorption, were good (κ = 0.61 to 0.80) to excellent (κ > 0.80). Lymphadenopathy, complex joint effusion, and edematous synovitis had sensitivities of >85%, specificities of >90%, odds ratios of >3.6, and AUC values of >0.90 for diagnosing PSI. The presence of all 3 findings together yielded a PSI probability of >99%, per logistic regression analysis. CONCLUSIONS: Our study shows the clinical utility of advanced MARS-MRI for diagnosing PSI when using the ICM 2018 criteria as the reference standard. Although the reliability and diagnostic accuracy were high, these conclusions are based on our specific advanced MARS-MRI protocol interpreted by experienced musculoskeletal radiologists. Investigations with larger sample sizes are needed to confirm these results. LEVEL OF EVIDENCE: Diagnostic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Fritz J, Meshram P, Stern SE, et al. Diagnostic Performance of Advanced Metal Artifact Reduction MRI for Periprosthetic Shoulder Infection. J Bone Joint Surg Am. 2022. PMID: 35730745. doi:10.2106/JBJS.21.00912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。